Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.44 |
| ▸ | CDA | P32320 | 8/20 | 0.44 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.44 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.44 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HBB | P68871 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16019739 | 0.83 | P2RY2 (0.38) | PYGMCDASLC28A1SLC28A2SLC29A1 | |
| SCHEMBL15258224 | 0.83 | P2RY2 (0.38) | PYGMCDASLC28A1SLC28A2SLC29A1 | |
| SCHEMBL29323492 | 0.82 | ALDH1A1 (0.42) | PYGMCDASLC28A1SLC28A2SLC29A1 | |
| SCHEMBL29323123 | 0.82 | ALDH1A1 (0.42) | PYGMCDASLC28A1SLC28A2SLC29A1 | |
| SCHEMBL15277191 | 0.82 | UMPS (0.48) | — | |
| SCHEMBL18999742 | 0.82 | UMPS (0.48) | — | |
| SCHEMBL15803212 | 0.82 | UMPS (0.48) | — | |
| SCHEMBL15257897 | 0.82 | UMPS (0.48) | — | |
| SCHEMBL16450259 | 0.82 | UMPS (0.48) | — | |
| SCHEMBL17010785 | 0.82 | UMPS (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399403-A1 | MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN AND THEIR USE IN MEDICINE | BioNTech SE (DE) | 2023-12-14 | — | — | US | disclosed |
| US-20230338512-A1 | CORONAVIRUS VACCINE | BioNTech SE (DE) | 2023-10-26 | — | — | US | disclosed |
| US-11779659-B2 | RNA constructs and uses thereof | BioNTech SE (DE) | 2023-10-10 | — | — | US | disclosed |
| US-20230287088-A1 | BINDING AGENTS FOR CORONAVIRUS S PROTEIN | BioNTech SE (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230145774-A1 | TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION | TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779659-B2 | RNA constructs and uses thereof | RNGTT, RNMT, NSUN3 | PYGM 1363/4885CDA 630/4885SLC28A1 1543/4885 |
| US-20230145774-A1 | TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION | ICOS, STING1, EIF2AK2 | PYGM 2197/4885CDA 584/4885SLC28A1 2536/4885 |
| US-20230399403-A1 | MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN AND THEIR USE IN MEDICINE | PDCD1, CD274, PDCD1LG2 | PYGM 2189/4885CDA 45/4885SLC28A1 1917/4885 |
| US-20230287088-A1 | BINDING AGENTS FOR CORONAVIRUS S PROTEIN | SARS1, CD2BP2, RBM3 | PYGM 1971/4885CDA 996/4885SLC28A1 1426/4885 |
| US-20230338512-A1 | CORONAVIRUS VACCINE | SARS1, CD4, ACE2 | PYGM 1890/4885CDA 1165/4885SLC28A1 4459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.